Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
New York · cancer center | United States | 0 | 5,120 | 95,936 | #1 | ||
Baltimore · cancer center | United States | 0 | 2,962 | 42,161 | #10 | ||
Boston · hospital | United States | 0 | 3,584 | 55,693 | #16 | ||
Shanghai · hospital | China | none recorded | 0 | 2,872 | 31,534 | - | |
London · hospital | United Kingdom | none recorded | 0 | 1,946 | 24,827 | - | |
Barcelona · hospital | Spain | none recorded | 0 | 1,520 | 21,766 | - | |
Lyon · cancer center | France | none recorded | 0 | 1,061 | 14,344 | - | |
Naples · cancer center | Italy | none recorded | 0 | 979 | 17,774 | - | |
Changsha · cancer center | China | none recorded | 0 | 839 | 10,483 | - | |
Guangzhou · hospital | China | none recorded | 0 | 769 | 8,924 | - | |
Taipei · hospital | Taiwan | none recorded | 0 | 684 | 6,795 | - | |
Portland, OR · cancer center | United States | 0 | 539 | 7,500 | - | ||
Shanghai · hospital | China | none recorded | 0 | 503 | 6,828 | - | |
Ghent · hospital | Belgium | none recorded | 0 | 495 | 5,334 | - | |
Aurora, CO · cancer center | United States | 0 | 478 | 12,554 | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Indolent and smouldering systemic mastocytosis but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.